Last reviewed · How we verify

NCT07131579: Dexmedetomidin

Intravenous Regional Analgesia of Dexmedetomidine

ENROLLING BY INVITATION NA Last updated 21 January 2026
What this trial tests

NA trial testing Normal Saline in Dexmedetomidine Analgesia in 100 participants. Enrolling by invitation.

Timeline
12 January 2026
Primary endpoint
30 December 2026
30 August 2027

Quick facts

Lead sponsorMansoura University
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment100
Start date12 January 2026
Primary completion30 December 2026
Estimated completion30 August 2027
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Mansoura University

Who can join

Adults 18 to 60, any sex, with Dexmedetomidine Analgesia or Knee Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Dexmedetomidine is a highly selective α₂-adrenergic receptor agonist that exerts its effects by inhibiting the release of norepinephrine at presynaptic nerve terminals, leading to reduced sympathetic activity; This mechanism results in analgesia, sedation, and anxiolysis without significant respiratory depression

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Normal Saline

Trials testing the same drug.

Other Mansoura University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07131579.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing